Recurrent Pancreatic Carcinoma Completed Phase 1 Trials for Dinaciclib (DB12021)

Also known as: Pancreatic carcinoma recurrent / Pancreas carcinoma recurrent / Pancreatic cancer recurrent

IndicationStatusPhase
DBCOND0043478 (Recurrent Pancreatic Carcinoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01783171Dinaciclib and Akt Inhibitor MK2206 in Treating Patients With Pancreatic Cancer That Cannot Be Removed by SurgeryTreatment